Physician profile
Muhammad Talib
NPI 1700855640
$7,124.44
in general payments reported to CMS, 2019-2025
40 companies · $1,829 in 2025
The $1,829 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,922 · 2020: $275 · 2021: $492 · 2022: $711 · 2023: $850 · 2024: $1,046 · 2025: $1,829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,724.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,201.08 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Olympus Corporation of The Americas | $989.98 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $612.17 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $585.72 | 2019-2025 | Ofev, Jascayd |
| Actelion Pharmaceuticals US, INC. | $504.44 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Grifols USA, LLC | $455.15 | 2019-2025 | Prolastin-C Liquid |
| Insmed, INC. | $274.66 | 2023-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $227.23 | 2022-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $226.45 | 2019-2025 | Xywav |
| Takeda Pharmaceuticals U.S.A., INC. | $172.12 | 2023-2025 | Glassia |
| Electromed, INC. | $150.67 | 2022-2025 | Smartvest |
| Baxter Healthcare | $139.39 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Harmony Biosciences LLC | $138.86 | 2021-2024 | |
| Genzyme Corporation | $138.82 | 2019-2025 | |
| Philips North America LLC | $135.39 | 2021-2023 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Talib listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.